Certara and Selling Stockholders Complete $310 Million Secondary Offering
11.24.21
This is only gets display when printing
Simpson Thacher represented Certara, Inc. (“Certara”) and an entity affiliated with EQT AB (“EQT”) in connection with a secondary offering of common stock of Certara by EQT and other selling stockholders. The offering of 10,000,000 shares of Certara’s common stock raised approximately $310 million in gross proceeds, with the selling stockholders receiving all of the proceeds from the offering.
Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions and key regulatory agencies across 61 countries.
The Simpson Thacher team included Bill Brentani, Kelli Schultz, Jonathan Kachiu, and Danielle Bembry (Capital Markets); and Jonathan Goldstein, Jonathan Cantor and Scott Grundei (Tax).